Cameron John Turtle MD
Instructor, Medicine, University of Washington School of Medicine
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-228-1025
Are you Dr. Turtle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cameron Turtle, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center and is an Instructor at University of Washington School of Medicine.
Education & Training
University of Sydney Faculty of MedicineClass of 1993
Certifications & Licensure
WA State Medical License 2007 - 2022
Clinical Trials
- JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Start of enrollment: 2016 Nov 15
- huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia Start of enrollment: 2017 Nov 03
Publications & Presentations
PubMed
- Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma.Tamara J Bock, Chanukya K Colonne, Salvatore Fiorenza, Cameron J Turtle
Nature Reviews. Clinical Oncology. 2025-04-01 - Cytokine-mediated increase in endothelial-leukocyte interaction mediates brain capillary plugging during CAR T cell neurotoxicity.Lina Park, Yu-Tung Tsai, Hyun-Kyoung Lim, Lila D Faulhaber, Katelyn Burleigh
Biorxiv. 2025-02-25 - Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates.Nicholas E Petty, Stefan Radtke, Greta Kanestrom, Emily Fields, Olivier Humbert
Blood Advances. 2025-02-10
Press Mentions
Patient and Family Experience with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) and Polyneuropathy (ATTR-PN) Amyloidosis: Results of Two Focus GroupsFebruary 8th, 2021- Eureka Therapeutics Appoints Nobel Laureate Randy Schekman, Ph.D. To Its Scientific Advisory BoardNovember 9th, 2020
Fred Hutch at ASH: Latest CAR T Data – BCMA, CD19, CD20 – plus New Insights on Transplantation, Gene Therapy – and MoreNovember 21st, 2019- Join now to see all
